Use of relievers in patients with severe asthma on biologic therapy –a multidisciplinary approach

M. Rezelj (Golnik, Slovenia), P. Kopac (Golnik, Slovenia), I. Pocvavšek (Golnik, Slovenia), J. Tršan (Golnik, Slovenia), T. Morgan (Golnik, Slovenia), S. Škrgat (Golnik, Slovenia)

Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Session: Challenges and updates in nursing care around the world
Session type: E-poster session
Number: 584
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Rezelj (Golnik, Slovenia), P. Kopac (Golnik, Slovenia), I. Pocvavšek (Golnik, Slovenia), J. Tršan (Golnik, Slovenia), T. Morgan (Golnik, Slovenia), S. Škrgat (Golnik, Slovenia). Use of relievers in patients with severe asthma on biologic therapy –a multidisciplinary approach. 584

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A digital therapy for proactively managing exacerbations and delivering therapeutic benefit to patients with moderate to severe asthma
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019

Combination asthma medication and healthcare use in severe or difficult-to-treat asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Combination therapy versus separate therapy in real-life primary care asthma patients
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Pharmacological strategies for self-management of asthma exacerbations
Source: Eur Respir J 2006; 28: 182-199
Year: 2006



The use of omalizumab in the management of severe chronic paediatric asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


The cost-efficacy of combined anti-inflammatory therapy in the treatment of children in severe persistent asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003

Severe asthma and biologic therapies during COVID-19: supporting patients care with home administration of mepolizumab and omalizumab
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Biologic therapies in paediatric severe asthma
Source: ERS webinar 2020: Biologic therapies in paediatric severe asthma
Year: 2020


Two therapy option in patients with uncontrolled asthma
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018

Use of parenteral long-term bronchodilators in the management of severe and life-threatening asthma
Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma
Year: 2003


Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD
Source: ERJ Open Res, 4 (3) 00087-2018; 10.1183/23120541.00087-2018
Year: 2018



Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019
Year: 2019



Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019
Year: 2019



Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002

Physicians judge add-on omalizumab therapy as an effective treatment for patients with severe persistent allergic asthma: a pooled analysis
Source: Eur Respir J 2005; 26: Suppl. 49, 49s
Year: 2005

Identifying patients with severe asthma that will be benefit from biological therapy
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020


The need for a specialist multidisciplinary clinic to manage paediatric patients with severe asthma in the age of biologics
Source: International Congress 2019 – PG11 Severe paediatric asthma
Year: 2019


How often do asthma patients claim prescribed therapy?
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Year: 2017